Back
AtkinsRéalis Group, Inc. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
58
SNCAF
AtkinsRéalis Group, Inc.
Last Price:
$63.27
Seasonality Move:
6.49%
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$83.03
Seasonality Move:
-32.16%
Buy
58
AtkinsRéalis Group, Inc. (SNCAF)
is a Buy
Is AtkinsRéalis Group, Inc. a Buy, Sell or Hold?
-
The current AtkinsRéalis Group, Inc. [SNCAF] share price is $62.36. The Score for SNCAF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
SNCAF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNCAF Stock Price Chart
What is AtkinsRéalis Group, Inc.'s stock price today?
-
The AtkinsRéalis Group, Inc. share price today is $62.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNCAF is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.88The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
SNCAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.78 | Buy |
| Relative Strength Index (14 RSI): | 44.1 | Sell |
| Chaikin Money Flow: | 532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.38 - 64.1) | Sell |
| Bollinger Bands (100): | (64.19 - 72.21) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | -145421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.39 - 83.51) | Buy |
| Bollinger Bands (100): | (41.65 - 69.37) | Buy |
SNCAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.13 | Sell |
| 20-day SMA: | 62.55 | Sell |
| 50-day SMA: | 65.83 | Sell |
| 200-day SMA: | 63.48 | Sell |
| 8-day EMA: | 24.52 | Buy |
| 20-day EMA: | 11.26 | Buy |
| 50-day EMA: | 4.77 | Buy |
| 200-day EMA: | 1.23 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.2 | Sell |
| 20-day SMA: | 75.43 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 43.03 | Buy |
| 8-day EMA: | 83.79 | Sell |
| 20-day EMA: | 77.26 | Buy |
| 50-day EMA: | 67.4 | Buy |
| 200-day EMA: | 47.62 | Buy |
AtkinsRéalis Group, Inc. Earnings Growth & SNCAF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
AtkinsRéalis Group, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||